Cell Genesys To Build Memphis Cancer Vaccine Facility

Published February 2002

MEMPHIS, TENN. -

Cell Genesys, based in Foster City, Calif., plans to develop a 35,000-sf manufacturing facility in Memphis for the production of the GVAX cancer vaccine. Completion is scheduled for the end of 2002.  The company also plans to relocate its headquarters from Foster City to a new 280,000-sf facility in South San Francisco. In addition, a $60-million, 41,000-sf manufacturing plant is under construction in Hayward, Calif.

Copyright 2008 Tradeline Inc.
All Rights Reserved
ISSN: 1096-4894